Aligos Therapeutics, Inc. short interest in 2021
In 2021, Aligos Therapeutics, Inc.'s disclosed short interest ran from 3.29% of shares outstanding on 15 Jan 2021 to 5.30% on 31 Dec 2021, a change of +2.01 percentage points. The year's high was 5.30% on 31 Dec 2021 and its low 3.29% on 15 Jan 2021, averaging 4.31% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.27 days on 31 Mar 2021. Full history: Aligos Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 3.29% (15 Jan 2021)
- End of year
- 5.30% (31 Dec 2021)
- Change
- +2.01 pp
- High
- 5.30% (31 Dec 2021)
- Low
- 3.29% (15 Jan 2021)
- Average
- 4.31%
- Highest days to cover
- 32.27 (31 Mar 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 3.29% | 17.34 | |
| 29 Jan 2021 | 3.44% | 16.12 | |
| 12 Feb 2021 | 3.58% | 21.80 | |
| 26 Feb 2021 | 3.94% | 18.41 | |
| 15 Mar 2021 | 4.07% | 31.24 | |
| 31 Mar 2021 | 4.06% | 32.27 | 10-K filed, results (8-K) |
| 15 Apr 2021 | 4.20% | 27.46 | |
| 30 Apr 2021 | 4.27% | 27.06 | |
| 14 May 2021 | 4.22% | 31.28 | 10-Q filed, results (8-K) |
| 28 May 2021 | 4.11% | 16.61 | |
| 15 Jun 2021 | 4.09% | 14.09 | |
| 30 Jun 2021 | 4.48% | 6.59 | |
| 15 Jul 2021 | 4.62% | 2.83 | |
| 30 Jul 2021 | 4.84% | 7.11 | |
| 13 Aug 2021 | 4.38% | 9.18 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 4.22% | 16.37 | |
| 15 Sep 2021 | 4.07% | 4.45 | |
| 30 Sep 2021 | 4.46% | 7.55 | |
| 15 Oct 2021 | 4.55% | 11.59 | |
| 29 Oct 2021 | 4.67% | 14.60 | |
| 15 Nov 2021 | 4.51% | 11.20 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 4.99% | 20.56 | |
| 15 Dec 2021 | 5.12% | 11.78 | |
| 31 Dec 2021 | 5.30% | 7.73 |
See also: Aligos Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.